HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zheng-Hong Qin Selected Research

prostaglandin A1 (PGA1)

8/2006Enhancement of neuroprotection and heat shock protein induction by combined prostaglandin A1 and lithium in rodent models of focal ischemia.
3/2005Neuroprotective effects of prostaglandin A1 in animal models of focal ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zheng-Hong Qin Research Topics

Disease

21Ischemia
11/2020 - 03/2005
19Neoplasms (Cancer)
08/2022 - 04/2006
11Huntington Disease (Huntington's Disease)
01/2013 - 03/2002
9Neurodegenerative Diseases (Neurodegenerative Disease)
10/2022 - 04/2006
9Brain Ischemia (Cerebral Ischemia)
01/2021 - 03/2005
9Stroke (Strokes)
07/2018 - 05/2006
8Parkinson Disease (Parkinson's Disease)
08/2022 - 12/2002
8Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
03/2022 - 04/2008
8Inflammation (Inflammations)
01/2018 - 05/2006
8Pain (Aches)
01/2018 - 03/2006
7Infarction (Infarctions)
01/2017 - 03/2005
6Neuroinflammatory Diseases
10/2022 - 11/2018
6Ischemic Stroke
08/2022 - 01/2016
5Brain Injuries (Brain Injury)
03/2022 - 11/2012
5Reperfusion Injury
12/2020 - 11/2012
5Arthritis (Polyarthritis)
12/2016 - 02/2009
4Chronic Renal Insufficiency
01/2015 - 01/2013
4Brain Edema (Cerebral Edema)
12/2012 - 08/2006
3Cardiovascular Diseases (Cardiovascular Disease)
08/2022 - 11/2018
3Lung Neoplasms (Lung Cancer)
01/2020 - 09/2014
3Body Weight (Weight, Body)
04/2019 - 01/2014
3Hypoxia (Hypoxemia)
01/2019 - 08/2010
3Experimental Arthritis
01/2015 - 02/2009
3Proteinuria
01/2015 - 01/2013
3Hypertrophy
01/2009 - 12/2007
2Alzheimer Disease (Alzheimer's Disease)
08/2022 - 04/2022
2Obesity
08/2022 - 01/2021
2Brain Diseases (Brain Disorder)
01/2022 - 10/2021
2COVID-19
12/2020 - 01/2020
2Parkinsonian Disorders (Parkinsonism)
12/2019 - 09/2013
2Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 10/2018
2Hepatocellular Carcinoma (Hepatoma)
12/2018 - 07/2010
2Carcinoma (Carcinomatosis)
12/2018 - 10/2009
2Acute Kidney Injury (Acute Renal Failure)
01/2018 - 01/2013
2Fibrosis (Cirrhosis)
01/2015 - 12/2014
2Hypoalbuminemia
01/2015 - 01/2013
2Rupture
01/2013 - 04/2008
2Starvation
01/2013 - 12/2005
2Embolism (Embolus)
08/2011 - 01/2008

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
12/2019 - 03/2002
13NADP (NADPH)IBA
08/2022 - 05/2014
12VenomsIBA
01/2018 - 03/2006
11Neuroprotective AgentsIBA
03/2022 - 03/2005
8Glucose (Dextrose)FDA LinkGeneric
03/2022 - 08/2010
7Oxygen (Dioxygen)IBA
03/2022 - 08/2010
7Pharmaceutical PreparationsIBA
01/2019 - 01/2013
6Cobra Neurotoxin ProteinsIBA
12/2020 - 03/2006
5Doxorubicin (Adriamycin)FDA LinkGeneric
09/2017 - 01/2013
5NeurotoxinsIBA
09/2013 - 04/2006
5polyglutamineIBA
01/2012 - 03/2002
4Therapeutic UsesIBA
07/2018 - 11/2009
4Analgesics (Analgesic Drugs)IBA
01/2018 - 08/2006
4Messenger RNA (mRNA)IBA
11/2017 - 04/2008
4Small Interfering RNA (siRNA)IBA
01/2015 - 04/2009
4CrotoxinIBA
05/2012 - 04/2006
4NF-kappa B (NF-kB)IBA
10/2008 - 12/2002
3Reactive Oxygen Species (Oxygen Radicals)IBA
10/2022 - 12/2018
3Peptides (Polypeptides)IBA
04/2022 - 01/2017
3SynucleinsIBA
12/2021 - 01/2013
3EscinIBA
01/2019 - 10/2018
3Beclin-1IBA
01/2019 - 08/2010
3Biological ProductsIBA
01/2019 - 06/2008
33-methyladenineIBA
12/2018 - 08/2010
3CytokinesIBA
01/2018 - 02/2009
3CardiotoxinsIBA
01/2015 - 01/2014
3Cathepsin BIBA
10/2010 - 08/2008
3AtropineFDA LinkGeneric
09/2009 - 03/2006
2Adenosine Triphosphate (ATP)IBA
10/2022 - 01/2019
2Transcription Factors (Transcription Factor)IBA
10/2022 - 09/2017
2NAD (NADH)IBA
03/2022 - 01/2021
2EnzymesIBA
10/2021 - 04/2008
2NADPH Oxidases (NAD(P)H oxidase)IBA
10/2021 - 01/2021
21- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
12/2019 - 11/2018
2Dynamins (Dynamin)IBA
12/2019 - 01/2004
2acetovanillone (apocynin)IBA
01/2018 - 01/2017
2MelatoninIBA
11/2017 - 08/2011
2Proteasome Endopeptidase Complex (Proteasome)IBA
08/2015 - 06/2008
2Epirubicin (Ellence)FDA LinkGeneric
04/2015 - 09/2014
2ElectrolytesIBA
01/2015 - 01/2013
2Matrix Metalloproteinases (MMPs)IBA
01/2013 - 10/2009
2Sirolimus (Rapamycin)FDA Link
03/2012 - 05/2010
23-nitropropionic acidIBA
12/2009 - 04/2009
2Elapid Venoms (Cobra Venom)IBA
02/2009 - 09/2006
23- (2- (4- (3- chloro- 2- methylphenyl)- 1- piperazinyl)ethyl)- 5,6- dimethoxyindazoleIBA
01/2009 - 12/2007
2Endothelin-1 (Endothelin 1)IBA
01/2009 - 12/2007
23- (2- (4- (3- chloro- 2- methylphenyl)1- piperazinyl)ethyl)5,6- dimethoxy- 1- (4- imidazolylmethyl)- 1H- indazol dihydrochloride 3.5 hydrateIBA
01/2009 - 12/2007
2Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2009 - 12/2007
2NF-KappaB Inhibitor alphaIBA
10/2008 - 04/2008
2Oxidopamine (6 Hydroxydopamine)IBA
05/2008 - 05/2007
2Prostaglandins AIBA
04/2008 - 08/2006
2Naloxone (Narcan)FDA LinkGeneric
09/2006 - 03/2006
2prostaglandin A1 (PGA1)IBA
08/2006 - 03/2005
1Cytochromes c (Cytochrome c)IBA
10/2022
1Mitochondrial DNA (mtDNA)IBA
10/2022

Therapy/Procedure

4Therapeutics
07/2018 - 02/2005
4Sutures (Suture)
03/2012 - 04/2008
3Drug Therapy (Chemotherapy)
12/2018 - 09/2014
3Analgesia
12/2014 - 03/2006
2Intraperitoneal Injections
12/2020 - 01/2016
2Microspheres (Microsphere)
08/2011 - 01/2008